-
1
-
-
33845258748
-
Wogonin sensitizes resistant malignant cells to TNFα- and TRAIL-induced apoptosis
-
DOI 10.1182/blood-2006-03-011973
-
SC Fas S Baumann JY Zhu M Giaisi MK Treiber U Mahlknecht PH Krammer M Li-Weber 2006 Blood 108 3700 3706 10.1182/blood-2006-03-011973 1:CAS:528:DC%2BD28Xht1Kgs7%2FP 10.1182/blood-2006-03-011973 (Pubitemid 44864547)
-
(2006)
Blood
, vol.108
, Issue.12
, pp. 3700-3706
-
-
Fas, S.C.1
Baumann, S.2
Jia, Y.Z.3
Giaisi, M.4
Treiber, M.K.5
Mahlknecht, U.6
Krammer, P.H.7
Li-Weber, M.8
-
2
-
-
33845221022
-
TRAIL promotes metastasis of human pancreatic ductal adenocarcinoma
-
DOI 10.1038/sj.onc.1209719, PII 1209719
-
A Trauzold D Siegmund B Schniewind B Sipos J Egberts D Zorenkov D Emme C Röder H Kalthoff H Wajant 2006 Oncogene 25 7434 7439 10.1038/sj.onc.1209719 1:CAS:528:DC%2BD28Xht1Kisr7P 10.1038/sj.onc.1209719 (Pubitemid 44853434)
-
(2006)
Oncogene
, vol.25
, Issue.56
, pp. 7434-7439
-
-
Trauzold, A.1
Siegmund, D.2
Schniewind, B.3
Sipos, B.4
Egberts, J.5
Zorenkov, D.6
Emme, D.7
Roder, C.8
Kalthoff, H.9
Wajant, H.10
-
3
-
-
33845642523
-
Difference of growth-inhibitory effect of Scutellaria baicalensis-producing flavonoid wogonin among human cancer cells and normal diploid cell
-
DOI 10.1016/j.canlet.2006.01.011, PII S0304383506000553
-
M Himeji T Ohtsuki H Fukazawa M Tanaka S Yazaki S Ui K Nishio H Yamamoto K Tasaka A Mimura 2007 Cancer Lett 245 269 274 10.1016/j.canlet.2006.01.011 1:CAS:528:DC%2BD2sXht1egtQ%3D%3D 10.1016/j.canlet.2006.01.011 (Pubitemid 44959358)
-
(2007)
Cancer Letters
, vol.245
, Issue.1-2
, pp. 269-274
-
-
Himeji, M.1
Ohtsuki, T.2
Fukazawa, H.3
Tanaka, M.4
Yazaki, S.-i.5
Ui, S.6
Nishio, K.7
Yamamoto, H.8
Tasaka, K.9
Mimura, A.10
-
4
-
-
33748421494
-
Protective role of wogonin against lipopolysaccharide-induced angiogenesis via VEGFR-2, not VEGFR-1
-
DOI 10.1016/j.intimp.2006.07.003, PII S1567576906002037
-
CM Lin H Chang YH Chen SY Li IH Wu JH Chiu 2006 Int Immunopharmacol 6 1690 1698 10.1016/j.intimp.2006.07.003 1:CAS:528:DC%2BD28Xps1Cmsbs%3D 10.1016/j.intimp.2006.07.003 (Pubitemid 44344541)
-
(2006)
International Immunopharmacology
, vol.6
, Issue.11
, pp. 1690-1698
-
-
Lin, C.-M.1
Chang, H.2
Chen, Y.-H.3
Li, S.Y.4
Wu, I.-H.5
Chiu, J.-H.6
-
5
-
-
41749102871
-
-
10.1016/j.lfs.2008.02.013 1:CAS:528:DC%2BD1cXks12kt78%3D 10.1016/j.lfs.2008.02.013
-
N Lu Y Gao Y Ling Y Chen Y Yang HY Gu Q Qi W Liu XT Wang QD You QL Guo 2008 Life Sci 82 956 963 10.1016/j.lfs.2008.02.013 1:CAS:528: DC%2BD1cXks12kt78%3D 10.1016/j.lfs.2008.02.013
-
(2008)
Life Sci
, vol.82
, pp. 956-963
-
-
Lu, N.1
Gao, Y.2
Ling, Y.3
Chen, Y.4
Yang, Y.5
Gu, H.Y.6
Qi, Q.7
Liu, W.8
Wang, X.T.9
You, Q.D.10
Guo, Q.L.11
-
6
-
-
48949099697
-
-
10.1016/j.ejphar.2008.06.024 1:CAS:528:DC%2BD1cXps12lu70%3D 10.1016/j.ejphar.2008.06.024
-
HW Zhang Y Yang K Zhang L Qiang L Yang L Yang Y Hu XT Wang QD You QL Guo 2008 Eur J Pharmacol 591 7 12 10.1016/j.ejphar.2008.06.024 1:CAS:528: DC%2BD1cXps12lu70%3D 10.1016/j.ejphar.2008.06.024
-
(2008)
Eur J Pharmacol
, vol.591
, pp. 7-12
-
-
Zhang, H.W.1
Yang, Y.2
Zhang, K.3
Qiang, L.4
Yang, L.5
Yang, L.6
Hu, Y.7
Wang, X.T.8
You, Q.D.9
Guo, Q.L.10
-
7
-
-
41349113805
-
-
10.1111/j.1349-7006.2008.00728 1:CAS:528:DC%2BD1cXlsFKjs7s%3D 10.1111/j.1349-7006.2008.00728.x
-
K Zhang QL Guo QD You Y Yang HW Zhang L Yang HY Gu Q Qi Z Tan X Wang 2008 Cancer Sci 99 689 695 10.1111/j.1349-7006.2008.00728 1:CAS:528: DC%2BD1cXlsFKjs7s%3D 10.1111/j.1349-7006.2008.00728.x
-
(2008)
Cancer Sci
, vol.99
, pp. 689-695
-
-
Zhang, K.1
Guo, Q.L.2
You, Q.D.3
Yang, Y.4
Zhang, H.W.5
Yang, L.6
Gu, H.Y.7
Qi, Q.8
Tan, Z.9
Wang, X.10
-
9
-
-
1542497833
-
-
10.1248/bpb.26.911 1:CAS:528:DC%2BD3sXmsFWnsLs%3D 10.1248/bpb.26.911
-
F Zuo ZM Zhou Q Zhang D Mao YL Xiong YL Wang MZ Yan ML Liu 2003 Biol Pharm Bull 26 911 919 10.1248/bpb.26.911 1:CAS:528:DC%2BD3sXmsFWnsLs%3D 10.1248/bpb.26.911
-
(2003)
Biol Pharm Bull
, vol.26
, pp. 911-919
-
-
Zuo, F.1
Zhou, Z.M.2
Zhang, Q.3
Mao, D.4
Xiong, Y.L.5
Wang, Y.L.6
Yan, M.Z.7
Liu, M.L.8
|